Related Experiment Video
Updated: Apr 15, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
The Challenge of Antimicrobial Resistance in Managing Intra-Abdominal Infections
Massimo Sartelli1, Fausto Catena2, Salomone di Saverio3
11Department of Surgery, Macerata Hospital, Macerata, Italy.
Background:
In recent years, there has been a worldwide increase in infections caused by microorganisms resistant to multiple antimicrobial agents.
Methods:
In the past few decades, an increased prevalence of infections caused by antibiotic-resistant pathogens, including Enterococcus spp., carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp., carbapenemase-producing Klebsiella pneumoniae, and resistant Candida spp., also has been observed among intra-abdominal infections (IAIs).
Results:
The increasing prevalence of multi-drug resistance is responsible for a substantial increase in morbidity and mortality rates associated with IAIs.
Conclusions:
It is necessary for every surgeon treating IAIs to understand the underlying epidemiology and clinical consequences of antimicrobial resistance. Emergence of drug resistance, combined with the lack of new agents in the drug development pipeline, indicates that judicious antimicrobial management will be necessary to preserve the utility of the drugs available currently.
Insights
Antimicrobial resistance is rising globally, leading to more severe intra-abdominal infections (IAIs). Judicious antibiotic use is crucial to preserve current treatments due to a lack of new drug development.
Area of Science:
- Infectious Diseases
- Microbiology
- Surgical Infections
Background:
- Worldwide increase in infections caused by multidrug-resistant microorganisms.
- Rising prevalence of antibiotic-resistant pathogens in intra-abdominal infections (IAIs), including specific bacteria and fungi.
- Observed increase in pathogens like carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and ESBL-producing E. coli.
Purpose of the Study:
- To highlight the growing challenge of antimicrobial resistance in IAIs.
- To emphasize the clinical consequences of multidrug-resistant infections.
- To underscore the need for understanding antimicrobial resistance epidemiology.
Main Methods:
- Observational analysis of trends in antimicrobial resistance.
- Review of pathogens commonly associated with IAIs.
- Assessment of the impact of resistance on morbidity and mortality.
Main Results:
- Increased prevalence of multi-drug resistant pathogens in IAIs.
- Significant rise in morbidity and mortality rates linked to IAIs.
- Specific resistant organisms identified as major contributors.
Conclusions:
- Surgeons must understand the epidemiology and clinical impact of antimicrobial resistance in IAIs.
- Limited new antimicrobial agents in development necessitate careful drug management.
- Judicious antimicrobial stewardship is essential to maintain the efficacy of existing treatments.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management

